Etiracetam

Etiracetam is a chemical compound belonging to the racetam family, which was developed as a nootropic drug. It is racemic; its biologically active enantiomeric form is levetiracetam, now marketed as an antiepileptic drug.[1]

Etiracetam
Clinical data
Routes of
administration
Oral
ATC code
  • none
Legal status
Legal status
  • US: Unscheduled
Identifiers
  • (RS)-2-(2-Oxopyrrolidin-1-yl)butanamide
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.111.445
Chemical and physical data
FormulaC8H14N2O2
Molar mass170.212 g·mol−1
3D model (JSmol)
ChiralityRacemic mixture
  • CCC(C(=O)N)N1CCCC1=O
  • InChI=1S/C8H14N2O2/c1-2-6(8(9)12)10-5-3-4-7(10)11/h6H,2-5H2,1H3,(H2,9,12) checkY
  • Key:HPHUVLMMVZITSG-UHFFFAOYSA-N checkY
 ☒NcheckY (what is this?)  (verify)

See also

References

  1. Sara SJ (1980). "Memory retrieval deficits: alleviation by etiracetam, a nootropic drug". Psychopharmacology. 68 (3): 235–41. doi:10.1007/bf00428109. PMID 6771807. S2CID 23369972.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.